U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542184) titled 'Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama' on April 14.
Brief Summary: The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Knee Cartilage Lesions
Intervention:
DEVICE: Nanochon Chondrograft
Mini arthrotomy or arthroscopic surgical implantation of Nanochon Chondrograft
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Nanochon,...